Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor

Journal: Cell

Published: 2018-10-12

DOI: 10.1016/j.cell.2018.09.038

Affiliations: 16

Authors: 31

Go to article
Institutions FC
Beijing Neurosurgical Institute at Beijing Tiantan Hospital, Capital Medical University, China 0.55
Institute for Refractory Cancer Research, SMC, South Korea 0.11
Division of Life Science, HKUST, China 0.07
Department of Oncology at Beijing Shijitan Hospital, Capital Medical University, China 0.06
Department of Radio-therapy at Beijing Tiantan Hospital, Capital Medical University, China 0.05
Center of Systems Biology and Human Health, HKUST, China 0.04
Department of Chemical and Biological Engineering (CBE), HKUST, China 0.04
State Key Laboratory of Cognitive Neuroscience and Learning, BNU, China 0.02
Beijing Key Laboratory of Gene Resource and Molecular Development, BNU, China 0.02
Jockey Club Institute for Advanced Study (IAS), HKUST, China 0.01
Department of Neurosurgery, SMC, South Korea 0.01
Sungkyunkwan University School of Medicine (SKKUSM), South Korea 0.01
Center of Brain Tumor, Capital Medical University, China 0.01
China National Clinical Research Center for Neurological Diseases (NCRC-ND) at Beijing Tiantan Hospital, Capital Medical University, China 0.01

Return